Multi-center, Double-blind, Randomized, Placebo Controlled, Parallel-group Study Comparing Taro Product to RLD and Both Active Treatments to a Placebo Control in the Treatment of Scalp Psoriasis
Latest Information Update: 28 Mar 2019
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- Sponsors Taro Pharmaceuticals USA
Most Recent Events
- 28 Mar 2019 New trial record